263 related articles for article (PubMed ID: 24685286)
21. Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India.
Kaur H; Sehgal R; Kumar A; Bharti PK; Bansal D; Mohapatra PK; Mahanta J; Sultan AA
BMC Infect Dis; 2020 Sep; 20(1):671. PubMed ID: 32933490
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
23. Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported
Bansal D; Acharya A; Bharti PK; Abdelraheem MH; Elmalik A; Abosalah S; Khan FY; ElKhalifa M; Kaur H; Mohapatra PK; Sehgal R; Idris MA; Mahanta J; Singh N; Babiker HA; Sultan AA
Am J Trop Med Hyg; 2017 Dec; 97(6):1797-1803. PubMed ID: 29016333
[No Abstract] [Full Text] [Related]
24. Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.
Kim YK; Kim C; Park I; Kim HY; Choi JY; Kim JM
Am J Trop Med Hyg; 2011 Apr; 84(4):532-4. PubMed ID: 21460004
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of molecular markers associated with chloroquine resistance in Plasmodium vivax strains from vivax malaria cases in Yunnan Province, China.
Ding H; Dong Y; Deng Y; Xu Y; Liu Y; Wu J; Chen M; Zhang C; Zheng W
Malar J; 2023 Jun; 22(1):181. PubMed ID: 37303047
[TBL] [Abstract][Full Text] [Related]
27. Assessment of drug resistance associated genetic diversity in Mauritanian isolates of Plasmodium vivax reveals limited polymorphism.
Mint Deida J; Ould Khalef Y; Mint Semane E; Ould Ahmedou Salem MS; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A; Tahar R
Malar J; 2018 Nov; 17(1):416. PubMed ID: 30409138
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana.
Faway E; Musset L; Pelleau S; Volney B; Casteras J; Caro V; Menard D; Briolant S; Legrand E
Malar J; 2016 Nov; 15(1):540. PubMed ID: 27825387
[TBL] [Abstract][Full Text] [Related]
29. Molecular surveillance of the Plasmodium vivax multidrug resistance 1 gene in Peru between 2006 and 2015.
Villena FE; Maguiña JL; Santolalla ML; Pozo E; Salas CJ; Ampuero JS; Lescano AG; Bishop DK; Valdivia HO
Malar J; 2020 Dec; 19(1):450. PubMed ID: 33276776
[TBL] [Abstract][Full Text] [Related]
30. Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination.
Ngassa Mbenda HG; Wang M; Guo J; Siddiqui FA; Hu Y; Yang Z; Kittichai V; Sattabongkot J; Cao Y; Jiang L; Cui L
Parasit Vectors; 2020 Feb; 13(1):67. PubMed ID: 32051017
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
[TBL] [Abstract][Full Text] [Related]
32. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
[TBL] [Abstract][Full Text] [Related]
33. Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in India.
Das S; Tripathy S; Chattopadhayay S; Das B; Kar Mahapatra S; Hati AK; Roy S
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):251-261. PubMed ID: 28692943
[TBL] [Abstract][Full Text] [Related]
34. Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.
Popovici J; Pierce-Friedrich L; Kim S; Bin S; Run V; Lek D; Hee KHD; Lee Soon-U L; Cannon MV; Serre D; Menard D
J Infect Dis; 2019 Jan; 219(2):315-322. PubMed ID: 30102351
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel.
Chung DI; Jeong S; Dinzouna-Boutamba SD; Yang HW; Yeo SG; Hong Y; Goo YK
Malar J; 2015 Sep; 14():336. PubMed ID: 26337571
[TBL] [Abstract][Full Text] [Related]
36. Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.
Mallick PK; Joshi H; Valecha N; Sharma SK; Eapen A; Bhatt RM; Srivastava HC; Sutton PL; Dash AP; Bhasin VK
Malar J; 2012 Jan; 11():16. PubMed ID: 22236376
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia.
Ketema T; Bacha K; Birhanu T; Petros B
Malar J; 2009 Jul; 8():177. PubMed ID: 19642976
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of molecular markers associated with drug resistance of Plasmodium vivax isolates in Western Yunnan Province, China.
Wang X; Ruan W; Zhou S; Feng X; Yan H; Huang F
BMC Infect Dis; 2020 Apr; 20(1):307. PubMed ID: 32334523
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.
Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET
Acta Trop; 2011 Feb; 117(2):69-75. PubMed ID: 20933490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
